Unsettled issues of Zostavax vaccine
- PMID: 22696015
- DOI: 10.1093/cid/cis546
Unsettled issues of Zostavax vaccine
Comment on
-
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30. Clin Infect Dis. 2012. PMID: 22291101 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical